Wipro on Wednesday posted a 6.3 per cent year-on-year (YoY) decline in its net profit at Rs 2,326.1 crore for the quarter ended March 31, 2020
Revenue from operations stood at Rs 15,711 crore, up 4.69 per cent against Rs 15,006.3 crore in the corresponding quarter of the previous fiscal.
All that happened in the markets today
Net liabilities rise 3-17%, funds forced to borrow to meet redemption pressure
The relaxation will not help many of the listed players and it will be a while before activity begins for them. There coud be labour-related issues.
Thus far in the calendar year 2020, Bharti Airtel has outperformed the market by surging 17 per cent as compared to a 33 per cent decline in the HDFC stock price & 24 per cent fall in the S&P Sensex.
Moody's said the Indian NBFC industry has been affected given disruptions to India's economic activity from the coronavirus outbreak, which will weaken companies' credit profiles
At 11:03 am, the S&P BSE Capital Goods index, the top gainer among sectoral indices, was trading nearly 4 per cent higher at 12,071 points.
The government, in its detailed guidelines, allowed activities like agricultural, horticultural, farming, procurement of agri products and 'mandis' after April 20
The stock of the drug maker has rallied 47 per cent in the past six trading days, and was quoting close to its 52-week high level of Rs 882
L&T's stock has gained 17 per cent in the past six trading days
The company announced it was well-positioned on liquidity, with an 11-quarter low debt and adequate liquidity as well as a focus on generating further cash.
Brokerages believe the extension of lockdown can potentially wipe off a major portion of seasonal sales for RAC.
According to media reports, private equity giant Carlyle was looking to sell stake in Metropolis Healthcare
Here's a look at the top stocks that may remain in focus today
Wipro is slated to announce its Q4 numbers later in the day and most brokerages expect the company's revenue growth to come in at the lower end of the guided range of 0-2 per cent
The recent gains came on Monday after the company received the USFDA approval for its Nagpur facility
Fund managers have shunned risk, with equity allocations the lowest since the 2009 financial crisis
Both nosedived in mid-March amid panic selling and forced margin calls; each then recovered by about 20% as central banks and governments kicked in more stimulus
Worsening business conditions and sell-off by anchor investors have taken the stock southward